Mina Rakoski is a Gastroenterology physician affiliated with Loma Linda University. OpenAlex indexes 38 publications with 1,257 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
25865 Barton Rd
Ste 101
Loma Linda, CA 923543895
Telephone
909-558-3364Provider last certified this registry record 3 Nov 2023.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Mallinckrodt Hospital Products Inc.Program year202523 payments$53,478openpaymentsdata.cms.gov ↗
- Gilead Sciences, Inc.Program year202526 payments$25,872openpaymentsdata.cms.gov ↗
- Boston Scientific CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
43.5%Rifamycin Antibacterial16.1%Xifaxan100%Part D<11 patientsOsmotic Laxative13.7%Lactulose100%Part D<11 patients+ 2 more classes in this area
Cardiovascular
26.2%Beta blocker11.3%Carvedilol100%Part D≥13 patientsAldosterone antagonist (MRA)8.9%Spironolactone100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
22.6%Calcineurin inhibitor22.6%Tacrolimus100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Hepatic Encephalopathy is the Key Driver of Symptom Burden in a Longitudinal Cohort of Patients With Advanced Chronic Liver Disease: PAL-LIVER Substudy
The American Journal of Gastroenterology
2026 - Role of Proton Beam Radiotherapy (PBRT) in Downstaging or Bridging Patients with Hepatocellular Carcinoma (HCC) prior to Liver Transplantation (LT)
American Journal of Transplantation
2025 - Adrenal Metastases after Liver Transplantation for Hepatocellular Carcinoma
American Journal of Transplantation
2025 - Targets and study design for symptom-focused trials aimed at patients with cirrhosis: An expert consensus
Hepatology Communications
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Gary Fraser, MD
Loma Linda University
Jeffrey Rosenfeld, MD
Loma Linda University
Richard Robison, MD
Loma Linda University
Howard Gimbel, MD
Loma Linda University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”